Immune-Checkpoint Inhibitors in B-Cell Lymphoma

Immune-Checkpoint Inhibitors in B-Cell Lymphoma

For years, immunotherapy has been considered a viable and attractive treatment option for patients with cancer. Among the immunotherapy arsenal, the targeting of intratumoral immune cells by immune-checkpoint inhibitory agents has recently revolutionised the treatment of several subtypes of tumours....

Full description

Bibliographic Details
Main Authors: Marc Armengol, Juliana Carvalho Santos, Miranda Fernández-Serrano, Núria Profitós-Pelejà, Marcelo Lima Ribeiro, Gaël Roué
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cancers
Subjects:
immune checkpoint
lymphoid neoplasms
programmed death 1
cytotoxic T-lymphocyte antigen 4
monoclonal antibodies
combination therapies
Online Access:https://www.mdpi.com/2072-6694/13/2/214

Internet

https://www.mdpi.com/2072-6694/13/2/214

Similar Items